NCT04297709 Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis Status COMPLETED Phase N/A
NCT04279769 Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT04277819 The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management Status COMPLETED Phase N/A
NCT04259983 Investigation of Relationship Between Vascular Functions, Exercise Capacity, and Respiratory Functions in CF Status COMPLETED Phase N/A
NCT04249466 Diet, Physical Activity and Glucose Tolerance in Cystic Fibrosis. Exploratory Study. Status COMPLETED Phase N/A
NCT04235140 Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation Status COMPLETED Phase PHASE3
NCT04226118 Efficacy of an Infrared Visualization Technique for the Identification of the Peripheral Venous Access Site in Patients With Cystic Fibrosis Aged 12 Years and Older Status COMPLETED Phase NA
NCT04215796 Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF). Status UNKNOWN Phase NA
NCT04206436 CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04183790 Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older Status COMPLETED Phase PHASE3
NCT04176328 Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients Status COMPLETED Phase PHASE1